GD2CART for Osteosarcoma or Neuroblastoma


This study enrolls patients that have been diagnosed with osteosarcoma or neuroblastoma that has come back (relapsed) or has not responded to standard treatments (refractory). This study involves an investigational cellular therapy called GD2CART. The study will be testing different doses of the study drug to find the safest dose.

For More Information

Contact Us Online

Call 267-425-5544

Related Centers and Programs